Your browser doesn't support javascript.
loading
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.
Thomson, David J; Cruickshank, Clare; Baines, Helen; Banner, Russell; Beasley, Matthew; Betts, Guy; Bulbeck, Helen; Charlwood, Frances; Christian, Judith; Clarke, Matthew; Donnelly, Olly; Foran, Bernadette; Gillies, Callum; Griffin, Clare; Homer, Jarrod J; Langendijk, Johannes A; Lee, Lip Wai; Lester, James; Lowe, Matthew; McPartlin, Andrew; Miles, Elizabeth; Nutting, Christopher; Palaniappan, Nachi; Prestwich, Robin; Price, James M; Roberts, Clare; Roe, Justin; Shanmugasundaram, Ramkumar; Simões, Rita; Thompson, Anna; West, Catharine; Wilson, Lorna; Wolstenholme, Jane; Hall, Emma.
Afiliación
  • Thomson DJ; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Cruickshank C; The Institute of Cancer Research, London, United Kingdom.
  • Baines H; Radiotherapy Trials QA Group (RTTQA), The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Banner R; Swansea Bay University Health Board, Swansea, United Kingdom.
  • Beasley M; Bristol Cancer Institute, Bristol, United Kingdom.
  • Betts G; Manchester University NHS Foundation Trust. Manchester, United Kingdom.
  • Bulbeck H; Brainstrust - The Brain Cancer People, Cowes, United Kingdom.
  • Charlwood F; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Christian J; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Clarke M; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Donnelly O; Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom.
  • Foran B; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Gillies C; University College Hospitals London NHS Foundation Trust, London, United Kingdom.
  • Griffin C; The Institute of Cancer Research, London, United Kingdom.
  • Homer JJ; Manchester University NHS Foundation Trust. Manchester, United Kingdom.
  • Langendijk JA; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Lee LW; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Lester J; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Lowe M; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • McPartlin A; Princess Margaret Hospital, Toronto, Canada.
  • Miles E; Radiotherapy Trials QA Group (RTTQA), Mount Vernon Hospital, Northwood, United Kingdom.
  • Nutting C; The Institute of Cancer Research, London, United Kingdom.
  • Palaniappan N; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Prestwich R; Velindre NHS Trust, Cardiff, United Kingdom.
  • Price JM; The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Roberts C; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Roe J; The University of Manchester, Manchester, United Kingdom.
  • Shanmugasundaram R; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Simões R; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Thompson A; Imperial College, London, United Kingdom.
  • West C; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Wilson L; Radiotherapy Trials QA Group (RTTQA), Mount Vernon Hospital, Northwood, United Kingdom.
  • Wolstenholme J; University College Hospitals London NHS Foundation Trust, London, United Kingdom.
  • Hall E; The University of Manchester, Manchester, United Kingdom.
Clin Transl Radiat Oncol ; 38: 147-154, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36452431
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido